BIAF 0.97 (-10.19%)
US09076W1099Medical Diagnostics & ResearchDiagnostics & Research

BioAffinity Technologies (BIAF) Competitor Comparison

We are evaluating the key criteria listed to compare BioAffinity Technologies (BIAF) against its competitors in the Diagnostics & Research industry.

Performance 10 years - BIAF ranking 49 / 58

These are the competitors of BioAffinity Technologies in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.36K
3. Medpace Holdings MEDP
1.15K
4. RadNet RDNT
857.19
5. Natera NTRA
853.61
6. IDEXX Laboratories IDXX
487.9
7. DexCom DXCM
461.16
8. Mettler-Toledo MTD
327.3
9. Thermo Fisher Scientific TMO
313.27
10. Icon ICLR
312.89
11. Danaher DHR
303.93
12. Twist Bioscience TWST
290.31
13. NeoGenomics NEO
284.56
14. IQVIA Holdings IQV
254.43
15. CareDx CDNA
249.36
16. PerkinElmer PKI
247.07
17. Agilent Technologies A
232.89
18. Waters WAT
232.22
19. Charles River Laboratories CRL
200.5
20. Laboratory Corp of America Holdings LH
155.04
21. Quest Diagnostics DGX
142
22. Exact Sciences EXAS
116.65
23. Fulgent Genetics FLGT
113.9
24. Syneos Health SYNH
113.83
25. Inotiv NOTV
74.67
26. Qiagen QGEN
74.11
27. Meridian Bioscience VIVO
60.69
28. National Research NRC
41.09
29. Guardant Health GH
33.73
30. Ortho Clinical Diagnostics Holdings OCDX
13.74
31. Anixa Biosciences ANIX
-13.6
32. Bioventus BVS
-22.91
33. Neogen NEOG
-23.34
34. Illumina ILMN
-23.4
35. Olink Holding OLK
-26.82
36. Sotera Health SHC
-51.93
37. Myriad Genetics MYGN
-53.18
38. Sera Prognostics SERA
-57.63
39. Global Cord Blood CO
-66.57
40. Pacific Biosciences of California PACB
-70.54
41. Exagen XGN
-73.27
42. DarioHealth DRIO
-75.47
43. Enzo Biochem ENZ
-77.8
44. MaxCyte MXCT
-78.4
45. Personalis PSNL
-83.09
46. Co-Diagnostics CODX
-83.5
47. MDxHealth MDXH
-83.54
48. Psychemedics PMD
-84.12
49. bioAffinity Technologies BIAF
-87.5
50. Biodesix BDSX
-90.07
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.32
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Interpace Biosciences IDXG
-98.42
56. Trinity Biotech TRIB
-98.75
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.78

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.